Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, MA, USA.
Institute of Physical and Rehabilitation Medicine, University of Sao Paulo Medical School, Sao Paulo, Brazil.
Spinal Cord Ser Cases. 2021 Sep 27;7(1):87. doi: 10.1038/s41394-021-00448-9.
A randomized, sham-controlled clinical trial.
To test the effects of tDCS, combined with robotic training, on gait disability in SCI. Our hypothesis was that participants who received active tDCS would experience greater walking gains, as indexed by the WISCI-II, than those who received sham tDCS.
University of São Paulo, Brazil.
This randomized, double-blind study comprised 43 participants with incomplete SCI who underwent 30 sessions of active (n = 21) or sham (n = 22) tDCS (20 min, 2 mA) before every Lokomat session of 30 min (3 times a week over 12 weeks or 5 times a week over 6 weeks). The main outcome was the improvement in WISCI-II. Participants were assessed at baseline, after 15 and 30 sessions of Lokomat, and after three months of treatment.
There was a significant difference in the percentage of participants that improved in WISCI-II at the 30-session, compared with baseline: 33.3% in the sham group and 70.0% in the active group (p = 0.046; OR: 3.7; 95% CI: 1.0-13.5). At the follow-up, the improvement compared with baseline in the sham group was 35.0% vs. 68.4% for the active group (p = 0.046; OR: 3.7; 95% CI: 1.0-13.5). There was no significant difference at the 15-session.
Thirty sessions of active tDCS is associated with a significant improvement in walking, compared to sham. Moreover, 15 sessions had no significant effect. The improvement in WISCI-II can be related to different aspects of motor learning, including motor recovery and compensation.
一项随机、假对照临床试验。
测试 tDCS 联合机器人训练对 SCI 步态障碍的影响。我们的假设是,接受主动 tDCS 的参与者在 WISCI-II 上的步行获益将大于接受假 tDCS 的参与者。
巴西圣保罗大学。
这项随机、双盲研究纳入了 43 名不完全性 SCI 患者,他们在每次 Lokomat 治疗前接受 30 次主动(n=21)或假(n=22)tDCS(20 分钟,2 mA)治疗,共 12 周(每周 3 次)或 6 周(每周 5 次)。主要结果是 WISCI-II 的改善。参与者在基线、15 次和 30 次 Lokomat 治疗后以及治疗后 3 个月进行评估。
与基线相比,30 次治疗后 WISCI-II 改善的参与者比例有显著差异:假治疗组为 33.3%,主动治疗组为 70.0%(p=0.046;OR:3.7;95%CI:1.0-13.5)。在随访时,与基线相比,假治疗组的改善为 35.0%,主动治疗组为 68.4%(p=0.046;OR:3.7;95%CI:1.0-13.5)。在 15 次治疗时没有显著差异。
与假 tDCS 相比,30 次主动 tDCS 治疗与步行显著改善相关。此外,15 次治疗没有显著效果。WISCI-II 的改善可能与运动学习的不同方面有关,包括运动恢复和补偿。